AA
HLVX

ALPS Advisors’s HilleVax HLVX Stock Holding History

ALPS Advisors’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-37,705
Closed -$66.4K – 1016
2024
Q3 		$66.4K Sell
37,705
-1,082
-3% -$2.77K ﹤0.01% 989
2024
Q2 		$561K Buy
+38,787
New +$533K ﹤0.01% 559
2023
Q4 		– Sell
-28,914
Closed -$389K – 983
2023
Q3 		$389K Buy
28,914
+102
+0.4% +$1.44K ﹤0.01% 629
2023
Q2 		$495K Buy
28,812
+6,839
+31% +$106K ﹤0.01% 616
2023
Q1 		$363K Sell
21,973
-641
-3% -$10.3K ﹤0.01% 663
2022
Q4 		$378K Buy
22,614
+4,317
+24% +$77.9K ﹤0.01% 700
2022
Q3 		$313K Sell
18,297
-1,528
-8% -$22.2K ﹤0.01% 712
2022
Q2 		$217K Buy
+19,825
New +$235K ﹤0.01% 984

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

ALPS Advisors's HLVX Position: Q4 2024 in Review

ALPS Advisors sold out of HilleVax (HLVX) in Q4 2024, closing a stake of 37,705 shares — an estimated $66.4K sold.

ALPS Advisors first reported a position in HLVX in Q2 2022 and held it in 8 quarters. The position peaked at $561K in Q2 2024. 76 funds tracked by Wall St. Rank hold HLVX as of Q4 2024.

  • ALPS Advisors reported no remaining HilleVax position as of Q4 2024 after selling out during the quarter.
  • ALPS Advisors sold 37,705 HilleVax shares in Q4 2024, an estimated $66.4K.
  • ALPS Advisors first reported a position in HilleVax in Q2 2022 and held it in 8 quarters.
  • ALPS Advisors's HilleVax position peaked at $561K in Q2 2024.
  • 76 funds tracked by Wall St. Rank held HilleVax as of Q4 2024.

Based on ALPS Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.